Filter By “Public Health”

post-image
Understanding the Long Term Effectiveness of Varying Doses of a New Therapy for Major Depression

A large biopharmaceutical client conducted a Phase II, 6-week, randomized, placebo-controlled, dose-finding trial to evaluate the efficacy, tolerability and safety of a new oral medication in patients with major depressive disorder who were not responding to antidepressant therapy.

Read More
post-image
Linking Oncology Diagnostic Labs to Assess their Effectiveness in Supporting Immunotherapy Treatment Selection in Lung Cancer

A molecular diagnostics company developed a blood test to support treatment selection for patients with advanced non-small cell lung cancer (NSCLC).

Read More
post-image
Provider and Non-Profit Info Center Website: Getting Started on Your Project with Datavant

In this webinar, viewers will learn about what Datavant does and how you can enrich your dataset to get a more complete picture of your patients.

Read More
post-image
5 Studies from the COVID-19 Research Database that Shaped Health Policy and Changed the COVID Conversation

In the early days of the pandemic, Datavant recognized a pressing need for national insight about COVID-19.

Read More
Health Data Trends Part I: Top Trends in Health Data Demand

As Head of Data Strategy at Datavant, I help clients find partners with relevant real-world data (RWD) for linkage to their own data or to create multi-partner linked datasets. These clients include pharmaceutical companies, health systems, government, payers, and analytics platforms. Connecting data helps them create a robust picture of patient health to accelerate research, improve care, and lower healthcare costs.

Read More
post-image
Research Using Connected Health Data
Read More
post-image
Amivantamab compared with real-world therapies in patients with NSCLC with EGFR Exon 20 insertion mutations who have progressed after platinum doublet chemotherapy

Amivantamab is an epidermal growth factor receptor (EGFR)-MET bispecific antibody with immune cell-directing activity.

LEARN MORE
Datavant Supports FDA Guidance with a Privacy-first Approach to Using Real World Evidence for Regulatory Decision Making

Datavant submitted comments on the recently issued FDA’s guidance that helped to clarify how real world data could be made “fit for purpose” in regulatory decision-making.

Read More
post-image
Variability in comorbidities and health services use across homeless typologies: multicenter data linkage between healthcare and homeless systems
LEARN MORE